Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 09:53 am Sale | 2022-12-31 | 13G | Keros Therapeutics, Inc. KROS | Deep Track Capital, LP | 0 0.000% | -1,300,000 (Position Closed) | Filing History |
| 2023-02-14 08:59 am Purchase | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Deep Track Capital, LP | 3,312,974 7.930% | 1,493,285 (+82.06%) | Filing History |
| 2023-02-14 08:59 am Purchase | 2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital, LP | 4,582,000 7.140% | 1,146,800 (+33.38%) | Filing History |
| 2023-02-14 08:58 am Sale | 2022-12-31 | 13G | TRICIDA INC TCDAQ | Deep Track Capital, LP | 4,666,666 7.440% | -1,191,163 (-20.33%) | Filing History |
| 2023-02-14 08:57 am Purchase | 2022-12-31 | 13G | Repare Therapeutics Inc. RPTX | Deep Track Capital, LP | 2,727,606 6.500% | 627,606 (+29.89%) | Filing History |
| 2023-02-14 08:56 am Purchase | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Deep Track Capital, LP | 2,837,818 9.430% | 356,818 (+14.38%) | Filing History |
| 2023-02-14 08:53 am Sale | 2022-12-31 | 13G | Passage Bio, Inc. PASG | Deep Track Capital, LP | 0 0.000% | -160,850 (Position Closed) | Filing History |
| 2023-02-14 08:52 am Sale | 2022-12-31 | 13G | Nuvation Bio Inc. NUVB | Deep Track Capital, LP | 8,221,188 3.760% | -3,250,093 (-28.33%) | Filing History |
| 2023-02-14 08:50 am Sale | 2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital, LP | 2,266,569 4.810% | -169,595 (-6.96%) | Filing History |
| 2023-02-14 08:50 am Sale | 2022-12-31 | 13G | Nkarta, Inc. NKTX | Deep Track Capital, LP | 1,354,200 2.770% | -611,484 (-31.11%) | Filing History |
| 2023-02-14 08:47 am Sale | 2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA | Deep Track Capital, LP | 3,000,000 4.950% | -1,870,000 (-38.40%) | Filing History |
| 2023-02-14 08:45 am Sale | 2022-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | Deep Track Capital, LP | 0 0.000% | -917,825 (Position Closed) | Filing History |
| 2023-02-14 08:44 am Sale | 2022-12-31 | 13G | Kura Oncology, Inc. KURA | Deep Track Capital, LP | 0 0.000% | -3,362,000 (Position Closed) | Filing History |
| 2023-02-14 08:42 am Purchase | 2022-12-31 | 13G | Chinook Therapeutics, Inc. KDNY | Deep Track Capital, LP | 3,000,000 4.690% | 247,930 (+9.01%) | Filing History |
| 2023-02-14 08:41 am Sale | 2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Deep Track Capital, LP | 0 0.000% | -1,500,000 (Position Closed) | Filing History |
| 2023-02-14 08:40 am Purchase | 2022-12-31 | 13G | Jounce Therapeutics, Inc. JNCE | Deep Track Capital, LP | 4,259,653 8.240% | 259,653 (+6.49%) | Filing History |
| 2023-02-14 08:39 am Sale | 2022-12-31 | 13G | IVERIC bio, Inc. ISEE | Deep Track Capital, LP | 7,878,119 5.880% | -1,121,881 (-12.47%) | Filing History |
| 2023-02-14 08:38 am Unchanged | 2022-12-31 | 13G | Inozyme Pharma, Inc. INZY | Deep Track Capital, LP | 3,250,000 8.050% | 0 (Unchanged) | Filing History |
| 2023-02-14 08:37 am Purchase | 2022-12-31 | 13G | Immunovant, Inc. IMVT | Deep Track Capital, LP | 9,710,000 7.520% | 2,929,173 (+43.20%) | Filing History |
| 2023-02-14 08:36 am Unchanged | 2022-12-31 | 13G | Immunic, Inc. IMUX | Deep Track Capital, LP | 4,022,989 8.320% | 0 (Unchanged) | Filing History |